VBIZF (Viva Biotech Holdings) Pretax Margin % : -9.15% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Viva Biotech Holdings's Pre-Tax Income for the six months ended in Dec. 2023 was $-13.0 Mil. Viva Biotech Holdings's Revenue for the six months ended in Dec. 2023 was $141.9 Mil. Therefore, Viva Biotech Holdings's pretax margin for the quarter that ended in Dec. 2023 was -9.15%.

The historical rank and industry rank for Viva Biotech Holdings's Pretax Margin % or its related term are showing as below:

VBIZF' s Pretax Margin % Range Over the Past 10 Years
Min: -51.11 Med: 22.99 Max: 86.96
Current: 4.54

VBIZF's Pretax Margin % is ranked better than
77.66% of 1007 companies
in the Biotechnology industry
Industry Median: -145.13 vs VBIZF: 4.54

Viva Biotech Holdings Pretax Margin % Historical Data

The historical data trend for Viva Biotech Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Pretax Margin % Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pretax Margin %

Get a 7-Day Free Trial

86.96

-51.11

16.52

-19.30

-2.60

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pretax Margin %	Get a 7-Day Free Trial										-5.73	-31.14	3.22	-9.15	18.90

Competitive Comparison of Viva Biotech Holdings's Pretax Margin %

For the Biotechnology subindustry, Viva Biotech Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viva Biotech Holdings's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's Pretax Margin % falls into.

Viva Biotech Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Viva Biotech Holdings's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-7.836	/	301.893
	=	-2.60 %

Viva Biotech Holdings's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-12.984	/	141.928
	=	-9.15 %

Viva Biotech Holdings (OTCPK:VBIZF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Viva Biotech Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (OTCPK:VBIZF) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

01873:Hong Kong VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.